DuPont (NYSE:DD) has changed unit heads.

DuPont Signals Unit Head Switch

DuPont (NYSE:DD) has announced several leadership changes.

Gary W. Spitzer has been named as senior vice president of Integrated Operations and Engineering, while Thierry Vanlancker will succeed Spitzer as president of DuPont (NYSE:DD) Chemicals and Fluoroproducts.

These changes are being made following the retirement of Jeffrey A. Coe after his 38 years of service.

Spitzer has served in a range of business and leadership roles for DuPont in the U.S., Germany and Hong Kong.

Vanlancker has held a variety of business leadership roles in sales, marketing and technical areas.

Dupont (NYSE:DD) stocks were at 52.70 at the end of the last day’s trading. There’s been a 11.9% change in the stock price over the past 3 months.

Dupont (NYSE:DD) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 1.69
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.64
Zack’s Rank: 11 out of 34 in the industry

Pfizer (NYSE:PFE)’s heart pill Inspra has gained a new license in the UK.

Pfizer Wins UK License

Under this new license, the drug maker giant Pfizer (NYSE:PFE) can use its Inspra pill to be used for the treatment of cardiovascular mortality and morbidity in adult patients with chronic heart failure and left ventricular systolic dysfunction.

Pfizer (NYSE:PFE) said that this new license, which is available to the NHS this week, is a cost effective use of the money as it can cut hospital admissions, and has an incremental cost per QALY gained of £3,534.

Pfizer Inc. (NYSE:PFE) shares were at 22.34 at the end of the last day’s trading. There’s been a 2.8% change in the stock price over the past 3 months.

Pfizer Inc. (NYSE:PFE) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 1.32
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.32
Zack’s Rank: 3 out of 14 in the industry

DuPont (NYSE:DD) MCM has introduced a new Solamet PV metallization paste.

DuPont Launches New Product

It has been reported that DuPont (NYSE:DD)’s division DuPont Microcircuit Materials (MCM) has launched DuPont Solamet PV416 photovoltaic metallization paste.

It is a new front-side silver paste material which is designed to raise the efficiency of thin-film photovoltaic cells.

DuPont (NYSE:DD) MCM stated that, “This new silver composition has the capability to be processed at temperatures lower than 140 degrees C and provides improved contact resistance, conductivity, adhesion and fine line resolution when printed on transparent conductive oxides (TCOs)”.

Dupont (NYSE:DD) shares were at 53.39 at the end of the last day’s trading. There’s been a 15.6% movement in the stock price over the past 3 months.

Dupont (NYSE:DD) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 1.69
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.64
Zack’s Rank: 10 out of 34 in the industry

Pfizer (NYSE:PFE) and Biocon have announced the conclusion of their commercialization agreement.

Pfizer Ending Commercialization Deal

The drug maker giant Pfizer (NYSE:PFE) and Biocon have agreed to end their alliance to commercialize Biocon’s biosimilar versions of Insulin and Insulin analog products.

Diem Nguyen, General Manager- Biosimilars Pfizer (NYSE:PFE) said, “Pfizer (NYSE:PFE) continues to be dedicated to developing a broad portfolio of biosimilars medicines, including monoclonal antibodies and recombinant proteins products, both internally and through collaborations. In addition, we will continue to be active in our own research and business development efforts for diabetes, which represents a huge unmet medical need, and we remain committed to seeking new solutions to help physicians and patients.”

Pfizer Inc. (NYSE:PFE) stocks are currently standing at 22.65.

Price History
Last Price: 22.65
52 Week Low / High: 16.63 / 22.8
50 Day Moving Average: 21.54
6 Month Price Change %: 28.1%
12 Month Price Change %: 11.5%

Pfizer (NYSE:PFE) and leading veterinary medical schools have collaborated for advanced veterinary medical education in China.

Pfizer To Push Vet Education In China

The animal health unit of Pfizer (NYSE:PFE) and International Veterinary Collaboration for China (IVCC), a consortium of leading veterinary medical schools in the United States and United Kingdom have signed a deal to collaborate with the Chinese Veterinary Medical Association (CVMA).

The deal is aimed at promoting advanced veterinary medical education and animal health in mainland China.

Dr. Michelle Haven, Vice President, Business Development, Global Alliances and Strategic Planning at Pfizer (NYSE:PFE) Animal Health said, “The memorandum of understanding marks a significant milestone for Pfizer (NYSE:PFE) Animal Health, our fellow IVCC partners and for China’s veterinary medicine profession.”

Pfizer Inc. (NYSE:PFE) shares were at 22.42 at the end of the last day’s trading. There’s been a 4.1% change in the stock price over the past 3 months.

Pfizer Inc. (NYSE:PFE) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 1.32
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.32
Zack’s Rank: 2 out of 14 in the industry

DuPont (NYSE:DD) has shown off its Powder Coating Solutions being used in a new luxury apartment building in Poland.

DuPont (NYSE:DD) Shows Off New Coating In Poland

DuPont (NYSE:DD) announced that the company will showcase powder coating solutions in a 54-floor luxury apartment building located in Poland.

DuPont (NYSE:DD)’s Alesta powder coatings will cover the façade of the new building for approximately 87,000 sq. m.

Elzbieta Wojciechowska-Zalewska, DuPont Coating Solutions’ country business manager, said that, “The DuPont powder coatings team in Poland endeavoured considerably in order to ensure DuPont solutions were used in this important project. Colleagues from Belgium supported this team”.

Dupont (NYSE:DD) stocks were at 52.75 at the end of the last day’s trading. There’s been a 16.5% change in the stock price over the past 3 months.

Dupont (NYSE:DD) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 1.69
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.64
Zack’s Rank: 12 out of 34 in the industry

Dow Chemical (NYSE:DOW) has partnered with the University of Queensland (UQ) on a new innovation centre.

Dow Chemical To Launch Australian Innovation Centre

Under this new deal, Dow Chemical (NYSE:DOW) will contribute about $10 million over the next six years for the University of Queensland (UQ) for the establishment of the Dow Centre for Sustainable Engineering Innovation.

Dow Chemical (NYSE:DOW) Chairman and Chief Executive Officer Andrew Liveris said, “The Center confirms our mutual commitment to sustainability through its focus on high impact outcomes of global significance and delivery of knowledge and leadership for future generations within an operational framework that provides economic prosperity while respecting community values and the environment.”

Dow Chemical (NYSE:DOW) company shares are currently standing at 34.12.

Price History
Last Price: 34.12
52 Week Low / High: 20.61 / 42.23
50 Day Moving Average: 34.03
6 Month Price Change %: 37.4%
12 Month Price Change %: -5.1%

Dow Chemical (NYSE:DOW) has decided to invest in a new manufacturing facility in Saudi Arabia.

Dow Chemical To Expand In Middle East

According to an announcement made by the company, the biggest U.S. chemical maker Dow Chemical (NYSE:DOW) is investing an undisclosed amount in a new manufacturing plant in Saudi Arabia for its Coating Materials business unit.

Jerome Peribere, executive vice president of Dow Chemical (NYSE:DOW) and president and chief executive officer, Dow Chemical (NYSE:DOW)’s Advanced Materials Division said, “By investing in a new coatings facility in Saudi Arabia, we are moving closer to our regional customers, and realizing our regional business objectives in a key growth market for Dow Chemical (NYSE:DOW).”

Dow Chemical (NYSE:DOW) shares are currently standing at 35.68.

Price History
Last Price: 35.68
52 Week Low / High: 20.61 / 42.23
50 Day Moving Average: 33.9
6 Month Price Change %: 48.8%
12 Month Price Change %: -4.7%